Identification of L-ferritin in Neuromelanin Granules of the Human Substantia Nigra

In the pigmented dopaminergic neurons of the human substantia nigra pars compacta the system relevant in iron storage is the polymer neuromelanin (NM). Although in most cells this function is mainly accomplished by ferritin, this protein complex appears not to be expressed in NM-containing neurons. Nevertheless the conceivable presence of iron-storing proteins as part of the NM granules has recently been discussed on the basis of Mössbauer spectroscopy and synchrotron x-ray microspectroscopy. Intriguingly by combining subcellular fractionation of NM granules, peptide sequencing via tandem mass spectrometry, and the additional confirmation by multiple reaction monitoring and immunogold labeling for electron microscopy, L-ferritin could now be unambiguously identified and localized in NM granules for the first time. This finding not only supports direct evidence for a regulatory role of L-ferritin in neuroectodermal cell pigmentation but also integrates a new player within a complicated network governing iron homeostasis in the dopamine neurons of the human substantia nigra. Thus our finding entails far reaching implications especially when considering etiopathogenetic aspects of Parkinson disease.

[1]  B. Bergamasco,et al.  Is neuromelanin changed in Parkinson’s disease? Investigations by magnetic spectroscopies , 2006, Journal of Neural Transmission.

[2]  K. Jellinger,et al.  Iron‐Melanin Complex in Substantia Nigra of Parkinsonian Brains: An X‐Ray Microanalysis , 1992, Journal of neurochemistry.

[3]  E. Parati,et al.  The chemical characterization of melanin contained in substantia nigra of human brain. , 1992, Biochimica et biophysica acta.

[4]  K. Jellinger,et al.  The role of transition metals in the pathogenesis of Parkinson's disease , 1995, Journal of the Neurological Sciences.

[5]  B. Bergamasco,et al.  EPR investigations of the iron domain in neuromelanin. , 1997, Biochimica et biophysica acta.

[6]  E. Flori,et al.  Ferritin light chain down‐modulation generates depigmentation in human metastatic melanoma cells by influencing tyrosinase maturation , 2006, Journal of cellular physiology.

[7]  J. Connor,et al.  Iron and iron management proteins in neurobiology. , 2001, Pediatric neurology.

[8]  P. Riederer,et al.  The enigma of neuromelanin in Parkinson's disease substantia nigra. , 1994, Journal of neural transmission. Supplementum.

[9]  J. Connor,et al.  Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.

[10]  J. Connor,et al.  A Quantitative Analysis of Isoferritins in Select Regions of Aged, Parkinsonian, and Alzheimer's Diseased Brains , 1995, Journal of neurochemistry.

[11]  A. Graybiel,et al.  Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease , 1988, Nature.

[12]  M. d’Ischia,et al.  Activation of mammalian tyrosinase by ferrous ions. , 1990, Biochimica et biophysica acta.

[13]  N. Wood,et al.  Dopa-Responsive Dystonia - The Story so Far , 2002, Neuropediatrics.

[14]  B. Bergamasco,et al.  Modifications of the iron–neuromelanin system in Parkinson's disease , 2006, Journal of neurochemistry.

[15]  B. Bergamasco,et al.  Magnetic investigations of human mesencephalic neuromelanin. , 2002, Biochimica et biophysica acta.

[16]  S. Ito,et al.  Does tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra? , 1998, Neuroscience Letters.

[17]  K. Jellinger,et al.  Brain iron and ferritin in Parkinson's and Alzheimer's diseases , 1990, Journal of neural transmission. Parkinson's disease and dementia section.

[18]  B. Bergamasco,et al.  Isolation and 13C‐NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.

[19]  G. Reynolds,et al.  Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain , 2005, Journal of Neural Transmission.

[20]  Y. Agid,et al.  Is the Vulnerability of Neurons in the Substantia Nigra of Patients with Parkinson's Disease Related to Their Neuromelanin Content? , 1992, Journal of neurochemistry.

[21]  P. Riederer,et al.  Iron-binding characteristics of neuromelanin of the human substantia nigra. , 2003, Biochemical pharmacology.

[22]  H. Meyer,et al.  Analysis of organelles within the nervous system: impact on brain and organelle functions , 2008, Expert review of proteomics.

[23]  K. Jellinger Rett Syndrome – an update , 2003, Journal of Neural Transmission.

[24]  W. Weckwerth,et al.  If the antibody fails – a mass Western approach , 2008, The Plant journal : for cell and molecular biology.

[25]  P. Harrison,et al.  The ferritins: molecular properties, iron storage function and cellular regulation. , 1996, Biochimica et biophysica acta.

[26]  H. M. Swartz,et al.  Interaction of neuromelanin and iron in substantia nigra and other areas of human brain , 1996, Neuroscience.

[27]  P. Riederer,et al.  Neuromelanin in human dopamine neurons: Comparison with peripheral melanins and relevance to Parkinson's disease , 2005, Progress in Neurobiology.

[28]  P. Riederer,et al.  Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases? , 1994, Journal of neurochemistry.

[29]  D. Berg,et al.  Brain iron pathways and their relevance to Parkinson's disease. , 2001, Journal of neurochemistry.

[30]  M Gallorini,et al.  Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes , 2001, Journal of neurochemistry.

[31]  R. Aebersold,et al.  Mass Spectrometry and Protein Analysis , 2006, Science.

[32]  P. Riederer,et al.  “Subcellular Proteomics” of Neuromelanin Granules Isolated from the Human Brain* , 2005, Molecular & Cellular Proteomics.

[33]  Peter Riederer,et al.  Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains , 1989, Journal of neurochemistry.

[34]  H. M. Swartz,et al.  Total and paramagnetic metals in human substantia nigra and its neuromelanin , 1993, Journal of neural transmission. Parkinson's disease and dementia section.

[35]  J. Connor Iron transport proteins in the diseased brain , 2003, Journal of the Neurological Sciences.

[36]  P. Riederer,et al.  Influence of neuromelanin on oxidative pathways within the human substantia nigra. , 2002, Neurotoxicology and teratology.

[37]  C. Marsden Tyrosinase Activity in the Pigmented Cells of the Nucleus Substantiae Nigrae: II. Further Observations on Monophenolase Activity , 1961 .

[38]  J. Foley,et al.  ON THE NATURE OF PIGMENT GRANULES IN THE CELLS OF THE LOCUS COERULEUS AND SUBSTANTIA NIGRA , 1958, Journal of neuropathology and experimental neurology.

[39]  P. Cloetens,et al.  Intracellular chemical imaging of the developmental phases of human neuromelanin using synchrotron X-ray microspectroscopy. , 2008, Analytical chemistry.

[40]  P. Riederer,et al.  Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexity , 2006, Journal of Neural Transmission.

[41]  P. Riederer,et al.  Subcellular proteomics reveals neuromelanin granules to be a lysosome-related organelle , 2006, Journal of Neural Transmission.

[42]  P. Riederer,et al.  Mössbauer Spectroscopic Studies of Purified Human Neuromelanin Isolated from the Substantia Nigra , 1995, Journal of neurochemistry.

[43]  R. Rydman,et al.  Decreased nigral neuromelanin in Alzheimer's disease , 2003, Neurological research.